SEI Medical PCL Statistics
Total Valuation
SEI Medical PCL has a market cap or net worth of THB 387.60 million. The enterprise value is 268.92 million.
| Market Cap | 387.60M |
| Enterprise Value | 268.92M |
Important Dates
The next estimated earnings date is Friday, February 27, 2026.
| Earnings Date | Feb 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SEI Medical PCL has 170.00 million shares outstanding. The number of shares has increased by 39.81% in one year.
| Current Share Class | 170.00M |
| Shares Outstanding | 170.00M |
| Shares Change (YoY) | +39.81% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 70.59% |
| Owned by Institutions (%) | n/a |
| Float | 50.00M |
Valuation Ratios
The trailing PE ratio is 7.05 and the forward PE ratio is 5.92.
| PE Ratio | 7.05 |
| Forward PE | 5.92 |
| PS Ratio | 0.82 |
| PB Ratio | 1.28 |
| P/TBV Ratio | 1.30 |
| P/FCF Ratio | 9.68 |
| P/OCF Ratio | 6.12 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.36, with an EV/FCF ratio of 6.71.
| EV / Earnings | 4.89 |
| EV / Sales | 0.57 |
| EV / EBITDA | 3.36 |
| EV / EBIT | 4.04 |
| EV / FCF | 6.71 |
Financial Position
The company has a current ratio of 2.54, with a Debt / Equity ratio of 0.31.
| Current Ratio | 2.54 |
| Quick Ratio | 1.80 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | 1.16 |
| Debt / FCF | 2.31 |
| Interest Coverage | 29.13 |
Financial Efficiency
Return on equity (ROE) is 19.25% and return on invested capital (ROIC) is 30.71%.
| Return on Equity (ROE) | 19.25% |
| Return on Assets (ROA) | 8.51% |
| Return on Invested Capital (ROIC) | 30.71% |
| Return on Capital Employed (ROCE) | 20.16% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 88 |
| Asset Turnover | 0.97 |
| Inventory Turnover | 2.47 |
Taxes
In the past 12 months, SEI Medical PCL has paid 12.45 million in taxes.
| Income Tax | 12.45M |
| Effective Tax Rate | 18.47% |
Stock Price Statistics
The stock price has decreased by -31.14% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -31.14% |
| 50-Day Moving Average | 2.22 |
| 200-Day Moving Average | 2.69 |
| Relative Strength Index (RSI) | 53.03 |
| Average Volume (20 Days) | 283,529 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SEI Medical PCL had revenue of THB 473.20 million and earned 54.96 million in profits. Earnings per share was 0.32.
| Revenue | 473.20M |
| Gross Profit | 158.73M |
| Operating Income | 66.56M |
| Pretax Income | 67.42M |
| Net Income | 54.96M |
| EBITDA | 77.85M |
| EBIT | 66.56M |
| Earnings Per Share (EPS) | 0.32 |
Balance Sheet
The company has 211.31 million in cash and 92.62 million in debt, with a net cash position of 118.68 million or 0.70 per share.
| Cash & Cash Equivalents | 211.31M |
| Total Debt | 92.62M |
| Net Cash | 118.68M |
| Net Cash Per Share | 0.70 |
| Equity (Book Value) | 302.14M |
| Book Value Per Share | 1.78 |
| Working Capital | 261.05M |
Cash Flow
In the last 12 months, operating cash flow was 63.36 million and capital expenditures -23.30 million, giving a free cash flow of 40.05 million.
| Operating Cash Flow | 63.36M |
| Capital Expenditures | -23.30M |
| Free Cash Flow | 40.05M |
| FCF Per Share | 0.24 |
Margins
Gross margin is 33.54%, with operating and profit margins of 14.07% and 11.62%.
| Gross Margin | 33.54% |
| Operating Margin | 14.07% |
| Pretax Margin | 14.25% |
| Profit Margin | 11.62% |
| EBITDA Margin | 16.45% |
| EBIT Margin | 14.07% |
| FCF Margin | 8.46% |
Dividends & Yields
This stock pays an annual dividend of 0.12, which amounts to a dividend yield of 5.17%.
| Dividend Per Share | 0.12 |
| Dividend Yield | 5.17% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 37.06% |
| Buyback Yield | -39.81% |
| Shareholder Yield | -34.63% |
| Earnings Yield | 14.18% |
| FCF Yield | 10.33% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SEI Medical PCL has an Altman Z-Score of 4.13 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.13 |
| Piotroski F-Score | 6 |